Updates on EPC, PCT, EPO case law and the e-EQE

EP 3 389 691 B1 relates to cyclic NTCP targeting peptides which are preS-derived peptides of hepatitis B virus (HBV). It also relates to medical uses of said cyclic peptides and the pharmaceutical compositions, such as in the diagnosis, prevention and/or treatment of a liver disease or condition, and/or in the inhibition of HBV and/or HDV infection.

EP 3 331 921 B1 relates to an inulin product.

Brief outline of the procedure

The patent was revoked by the OD for lack of sufficiency as the subject-matter of claims 1 and 7 of all requests was characterized by an amount of chains of fructose units with a terminal glucose of formula GFn with n>=10 which could not be measured.

EP 3 071 045 B1 relates to a method of extraction of pea proteins

Brief outline of the case

The patent was maintained according to AR6.

Both proprietor and both opponents appealed. Later, opponent 1 withdrew its appeal.

The patent was eventually maintained according to AR1 filed and admitted in appeal. 

EP 3 071 045 B1 relates to a method of extraction of pea proteins

Brief outline of the case

The patent was maintained according to AR6.

Both proprietor and both opponents appealed. Later, opponent 1 withdrew its appeal.

The patent was eventually maintained according to AR1 filed and admitted in appeal.

EP 3 658 692 B1 relates to a steel strip, sheet or blank for producing a hot formed part; a hot formed part, and a method for producing a hot formed part.

Brief outline of the case

The patent was maintained according to AR2 and the opponent appealed.

The board held that claim 1 as maintained were infringing Art 123(2).